Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies.
暂无分享,去创建一个
Silvio Massa | Rino Ragno | Silvia Simeoni | Antonello Mai | Dante Rotili | A. Mai | R. Ragno | D. Rotili | G. Brosch | S. Simeoni | A. Caroli | S. Massa | Gerald Brosch | Antonella Caroli | Giorgia Botta | G. Botta
[1] M. Guenther,et al. Biochemical isolation and analysis of a nuclear receptor corepressor complex. , 2003, Methods in enzymology.
[2] P. Marks,et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.
[3] C. Allis,et al. The language of covalent histone modifications , 2000, Nature.
[4] Silvio Massa,et al. Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. , 2002, Journal of medicinal chemistry.
[5] A. Mai,et al. 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies. , 2004, Journal of medicinal chemistry.
[6] Yukihiro Itoh,et al. Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. , 2006, Journal of medicinal chemistry.
[7] Ishihara,et al. Search for new charged leptons decaying into massive neutrinos and new stable charged leptons in e+e- collisions. , 1988, Physical review letters.
[8] S. Pickett,et al. GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.
[9] G. Brosch,et al. Purification of histone deacetylase HD1‐A of germinating maize embryos , 1996, FEBS letters.
[10] Silvio Massa,et al. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures. , 2003, Journal of medicinal chemistry.
[11] W. Helliger,et al. Different types of maize histone deacetylases are distinguished by a highly complex substrate and site specificity. , 1999, Biochemistry.
[12] G. Brosch,et al. Identification of maize histone deacetylase HD2 as an acidic nucleolar phosphoprotein. , 1997, Science.
[13] Stuart L Schreiber,et al. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Glaser,et al. Histone deacetylase inhibitors: the Abbott experience. , 2003, Current medicinal chemistry.
[15] Minoru Yoshida,et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. , 2002, Cancer research.
[16] Peter A. Kollman,et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .
[17] T. Tsuruo,et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] Ricardo Macarron,et al. Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases , 2003, Journal of Pharmacology and Experimental Therapeutics.
[19] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[20] A. Eberharter,et al. A comparative study of histone deacetylases of plant, fungal and vertebrate cells. , 1996, Biochimica et biophysica acta.
[21] F. Dequiedt,et al. Class II histone deacetylases: versatile regulators. , 2003, Trends in genetics : TIG.
[22] S. Horinouchi,et al. In vivo destabilization of dynamic microtubules by HDAC6‐mediated deacetylation , 2002, The EMBO journal.
[23] Ping Zhu,et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.
[24] A. Mai,et al. A NEW FACILE AND EXPEDITIOUS SYNTHESIS OF N-HYDROXY-N′-PHENYLOCTANEDIAMJDE, A POTENT INDUCER OF TERMINAL CYTODIFFERECNTIATION , 2001 .
[25] G. Brosch,et al. Biochemical methods for analysis of histone deacetylases. , 1998, Methods.
[26] H. Lindner,et al. Specificity of Zea mays histone deacetylase is regulated by phosphorylation. , 1992, The Journal of biological chemistry.
[27] Ismael Zamora,et al. Discriminant and quantitative PLS analysis of competitive CYP2C9 inhibitors versus non-inhibitors using alignment independent GRIND descriptors , 2002, J. Comput. Aided Mol. Des..
[28] Silvio Massa,et al. Histone deacetylation in epigenetics: An attractive target for anticancer therapy , 2005, Medicinal research reviews.
[29] A. Mai,et al. Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. , 2003, Journal of medicinal chemistry.
[30] G. Brosch,et al. Purification and characterization of a high molecular weight histone deacetylase complex (HD2) of maize embryos. , 1996, Biochemistry.
[31] L. Guarente,et al. The Sir2 family of protein deacetylases. , 2004, Annual review of biochemistry.
[32] J. Walton,et al. RPD3-type histone deacetylases in maize embryos. , 2000, Biochemistry.
[33] Silvio Massa,et al. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole-C2 and/or -C4 Substitutions on Biological Activity† , 2004 .
[34] O. Wiest,et al. On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors. , 2004, Journal of medicinal chemistry.
[35] Ferran Sanz,et al. Incorporating molecular shape into the alignment-free Grid-Independent Descriptors. , 2004, Journal of medicinal chemistry.
[36] A. Mai,et al. 3-(4-aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a new class of synthetic histone deacetylase inhibitors. , 2001, Journal of medicinal chemistry.
[37] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[38] T. Yao,et al. Molecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10* , 2002, The Journal of Biological Chemistry.
[39] J. R. Somoza,et al. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. , 2004, Structure.
[40] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.
[41] L. Altucci,et al. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. , 2005, Journal of medicinal chemistry.
[42] D. Condorelli,et al. Structure-based rationalization of antitumor drugs mechanism of action by a MIF approach. , 2004, European journal of medicinal chemistry.